# Phase II Study of RC1416 Injection in COPD

> clinical trial · VERIFIED · 2026-07-09

Status: RECRUITING · Sponsor: Nanjing RegeneCore Biotech Co., Ltd. · Condition: Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

- Company: Nanjing RegeneCore Biotech Co., Ltd.
- Sector: Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
- Primary source: https://clinicaltrials.gov/study/NCT07402551

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.